B. Guthrie

First name

B.

Last name

Guthrie

Livingstone, S. J., Guthrie, B., McMinn, M., Eke, C., Donnan, P. T., & Morales, D. R. (2023). Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study. Lancet Healthy Longev, 4, e43-e53. http://doi.org/10.1016/s2666-7568(22)00290-2

View

Livingstone, S. J., Guthrie, B., Donnan, P. T., Thompson, A., & Morales, D. R. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6

View

Morales, D. R., Dreischulte, T., Lipworth, B. J., Donnan, P. T., Jackson, C., & Guthrie, B. (2016). Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13006

View

Kontopantelis, E., Springate, D. A., Ashcroft, D. M., Valderas, J. M., van der Veer, S. N., Reeves, D., et al. (2016). Associations between exemption and survival outcomes in the UK\textquoterights primary care pay-for-performance programme: a retrospective cohort study. BMJ Qual Saf. http://doi.org/10.1136/bmjqs-2015-004602

View

Morales, D. R., Lipworth, B. J., Donnan, P. T., Jackson, C., & Guthrie, B. (2017). Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study. BMC Med. http://doi.org/10.1186/s12916-017-0781-0

View

Livingstone, S., Morales, D. R., Donnan, P. T., Payne, K., Thompson, A. J., Youn, J. H., & Guthrie, B. (2021). Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. Lancet Healthy Longev. http://doi.org/10.1016/s2666-7568(21)00088-x

View